Shareholders of Kenvue (KVUE) will vote on Kimberly-Clark’s (KMB) $48.7 billion acquisition proposal on Jan. 29, creating a consumer health and wellness powerhouse. The deal offers $21.01 per share, a premium over current trading levels, but KVUE stock is trading below the deal price. The proposed merger would unite two giants and unlock $2.1 billion in synergies. Kenvue’s operational struggles make the merger attractive, with analysts forecasting revenue to increase to $17 billion by 2029. Out of 12 analysts, 2 recommend a “Strong Buy” on KVUE stock.

Read more at Barchart: Kenvue Is Headed for a Merger Vote on January 29. How Should You Play KVUE Stock Here?